HomeCommunity Education Health InformationAsthma & Children


Yolo-Solano Air Quality Management District
1947 Galileo Ct., Suite 103
Davis, CA 95618

(530) 757-3650 or
(800) 287-3650
FAX (530) 757-3670

Ag Burn Line
(800) 246-3660 or
(530) 757-3660

The Yolo-Solano Air Quality Management District is dedicated to protecting human health and property from the harmful effects of air pollution.

webmaster@ysaqmd.org

Asthma & Children Fact Sheet

Asthma is a reversible obstructive lung disease, caused by an increased reaction of the airways to various stimuli. It is a chronic condition with acute exacerbations. Asthma can be a life-threatening disease if not properly managed. It is estimated that 6.3 million children under 18 years of age have asthma; of which 4 million suffered from an asthma attack or episode within the average year.

  • Asthma is the leading serious chronic illness among children. Most children have mild to moderate problems, and their illness can be controlled by treatment at home or in the doctor's office. For some children the illness becomes a formidable problem causing numerous visits to the hospital emergency room and multiple hospitalizations.
  • Asthma is the third leading cause of hospitalization among children under the age of 15 and it is the first-ranking chronic condition.
  • There were close to 658,000 pediatric emergency room visits in 1999 due to asthma. The estimated annual rate for emergency room visits among children under age 5 is 137.1 per 10,000--the highest rate of all age groups.
  • Asthma accounts for 14 million lost school days annually. It is the leading cause of school absenteeism attributed to chronic conditions.
  • The estimated annual cost of treating asthma in those under 18 years of age is $3.2 billion.
  • Asthma breathing problems usually happen in "episodes,"but the inflammation underlying asthma is continuous. An asthma episode is a series of events that result in narrowed airways. These include: swelling of the lining, tightening of the muscle, and increased secretion of mucus in the airway. The narrowed airway is responsible for the difficulty in breathing with the familiar "wheeze."
  • Asthma medications help reduce underlying inflammation in the airways and relieve or prevent symptomatic airway narrowing. Control of inflammation should lead to reduction in airway sensitivity and help prevent airway obstruction.
  • Two classes of medications have been used to treat asthma--anti-inflammatory agents and rescue medicines or bronchodilators. Anti-inflammatory drugs interrupt the development of bronchial inflammation and have a preventive action. They may also modify or terminate ongoing inflammatory reactions in the airways. These agents include corticosteroids, cromolyn sodium, and other anti-inflammatory compounds. A new class of anti-inflammatory medications known as leukotriene modifiers, which work in a different way by blocking the activity of chemicals called leukotrienes that are involved in airway inflammation, have recently become available.
  • Bronchodilators act principally to dilate the airways by relaxing bronchial smooth muscle. They include beta-adrenergic agonists, methylxanthines, and anticholinergics.
  • Asthma is characterized by excessive sensitivity of the lungs to various stimuli. Triggers range from viral infections to allergies, to irritating gases and particles in the air. Each child reacts differently to the factors that may trigger asthma, including:
    • respiratory infections, colds
    • allergic reactions to allergens such as pollen, mold, animal dander, feathers, dust, food, and cockroaches
    • allergic reactions to pollen, mold, animal dander, feather, dust, food
    • vigorous exercise
    • exposure to cold air or sudden temperature change
    • cigarette smoke
    • excitement/stress
    • exercise
For more information contact the American Lung Association

Home Board The District Announcements Contact Us